CLARIFY Trademark

Trademark Overview


On Monday, July 19, 2021, a trademark application was filed for CLARIFY with the United States Patent and Trademark Office. The USPTO has given the CLARIFY trademark a serial number of 90836111. The federal status of this trademark filing is THIRD EXTENSION - GRANTED as of Friday, May 24, 2024. This trademark is owned by Precision Therapeutics, LLC. The CLARIFY trademark is filed in the Medical Instrument Products category with the following description:

Real time Polymerase Chain Reaction lyophilized products for medical laboratories, namely, analyzers and apparatus for testing blood or bodily fluids for medical diagnostic purposes; Nasopharyngeal testing devices in the nature of probes for detection of infectious disease; Medical diagnostic testing apparatus for detection of nucleic acid from SARS-CoV-2; Medical diagnostic testing apparatus for testing for Influenza A, Influenza B, SARS, Covid-19, SARS-CoV-2, Coronavirus, and respiratory illnesses; Cell-based medical diagnostic testing apparatus for testing for Influenza A, Influenza B, SARS, Covid-19, SARS-CoV-2, Coronavirus, and respiratory illnesses; Rapid medical diagnostic testing apparatus for testing for Influenza A, Influenza B, Covid-19, SARS-CoV-2, Coronavirus, and respiratory illnesses; Medical diagnostic testing apparatus for testing for Influenza A, Influenza B, SARS, Covid-19, SARS-CoV- 2, Coronavirus, and respiratory illnesses for point of care, laboratory, and home us...
clarify

General Information


Serial Number90836111
Word MarkCLARIFY
Filing DateMonday, July 19, 2021
Status732 - THIRD EXTENSION - GRANTED
Status DateFriday, May 24, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 4, 2022

Trademark Statements


Goods and ServicesReal time Polymerase Chain Reaction lyophilized products for medical laboratories, namely, analyzers and apparatus for testing blood or bodily fluids for medical diagnostic purposes; Nasopharyngeal testing devices in the nature of probes for detection of infectious disease; Medical diagnostic testing apparatus for detection of nucleic acid from SARS-CoV-2; Medical diagnostic testing apparatus for testing for Influenza A, Influenza B, SARS, Covid-19, SARS-CoV-2, Coronavirus, and respiratory illnesses; Cell-based medical diagnostic testing apparatus for testing for Influenza A, Influenza B, SARS, Covid-19, SARS-CoV-2, Coronavirus, and respiratory illnesses; Rapid medical diagnostic testing apparatus for testing for Influenza A, Influenza B, Covid-19, SARS-CoV-2, Coronavirus, and respiratory illnesses; Medical diagnostic testing apparatus for testing for Influenza A, Influenza B, SARS, Covid-19, SARS-CoV- 2, Coronavirus, and respiratory illnesses for point of care, laboratory, and home use; Medical diagnostic antigen testing apparatus for testing for Human papillomavirus (HPV), Gene Factor V, Factor II Mutation, MTHFR Enzyme (C677T and A1298C), Coagulation FV, CC 13910 Genotype (Lactose Activity), HLA-B27 Blood Test, Ureaplasma, Mycoplasma Hominis, Mycoplasma genitalium, Gonorrhea, Ureaplasma Urealyticum, Celiac Disease, Tuberculosis, Clostridioides, MRSA (Staph Infection), HSV, Herpes Zoster (Shingles), Monkeypox, Polio, T-Cell Antibodies, Hepatitis B, Hepatitis C, Human Immunodeficiency Virus, Treponema Pallidum, Helicobacter Pylori, Malaria, Vibrio Cholerae, Dengue Virus, Rotavirus, Adenovirus, Group A Streptococcus, Chlamydia, Salmonella, Zika, Influenza A, Influenza B, Chagas, Chikungunya,HCG, FSH Menopause, Male Fertility, Human Chronic Gonadotrophin, LH Ovulation, Amphetamine, Barbiturates, Benzodiazepine, Cocaine, MDMA, Morphine (MOR), Opiates(OPI), Methadone (MTD), Tricyclic Antidepressants, Tetrahydrocannabinol (THC), Buprenorphine (BUP), Oxycodone (Oxy), Ketamine(KET), Phencyclidine (PCP), Marijuana (K2), Fentanyl (FYL), Fatty Acid, Troponin, Creatine Kinase Isoenzymnes, Myoglobin, C Reactive Protein, Covid-19, SARS-CoV-2, Coronavirus, Cancer, Staphylococcus,Blood Disorders, Vitamin levels, Respiratory Disease, SARS, Urinary Infections, Fertility, Cardiac Markers, Tumor Markers, Drug Abuse, Digestive and Immune Disorders, Sexually Transmitted Diseases (STD), Herpes, Infectious Diseases, and parvo; Rapid medical diagnostic antigen testing apparatus for testing for Human papillomavirus (HPV), Gene Factor V, Factor II Mutation, MTHFR Enzyme (C677T and A1298C), Coagulation FV, CC 13910 Genotype (Lactose Activity), HLA-B27 Blood Test, Ureaplasma, Mycoplasma Hominis, Mycoplasma genitalium, Gonorrhea, Ureaplasma Urealyticum, Celiac Disease, Tuberculosis, Clostridioides, MRSA (Staph Infection), HSV, Herpes Zoster (Shingles), Monkeypox, Polio, T-Cell Antibodies, Hepatitis B, Hepatitis C, Human Immunodeficiency Virus, Treponema Pallidum, Helicobacter Pylori, Malaria, Vibrio Cholerae, Dengue Virus, Rotavirus, Adenovirus, Group A Streptococcus, Chlamydia, Salmonella, Zika, Influenza A, Influenza B, Chagas, Chikungunya,HCG, FSH Menopause, Male Fertility, Human Chronic Gonadotrophin, LH Ovulation, Amphetamine, Barbiturates, Benzodiazepine, Cocaine, MDMA, Morphine (MOR), Opiates(OPI), Methadone (MTD), Tricyclic Antidepressants, Tetrahydrocannabinol (THC), Buprenorphine (BUP), Oxycodone (Oxy), Ketamine(KET), Phencyclidine (PCP), Marijuana (K2), Fentanyl (FYL), Fatty Acid, Troponin, Creatine Kinase Isoenzymnes, Myoglobin, C Reactive Protein, Covid-19, SARS-CoV-2, Coronavirus, Cancer, Staphylococcus,Blood Disorders, Vitamin levels, Respiratory Disease, SARS, Urinary Infections, Fertility, Cardiac Markers, Tumor Markers, Drug Abuse, Digestive and Immune Disorders, Sexually Transmitted Diseases (STD), Herpes, Infectious Diseases, and parvo; Medical diagnostic antigen testing apparatus for testing for Human papillomavirus (HPV), Gene Factor V, Factor II Mutation, MTHFR Enzyme (C677T and A1298C), Coagulation FV, CC 13910 Genotype (Lactose Activity), HLA-B27 Blood Test, Ureaplasma, Mycoplasma Hominis, Mycoplasma genitalium, Gonorrhea, Ureaplasma Urealyticum, Celiac Disease, Tuberculosis, Clostridioides, MRSA (Staph Infection), HSV, Herpes Zoster (Shingles), Monkeypox, Polio, T-Cell Antibodies, Hepatitis B, Hepatitis C, Human Immunodeficiency Virus, Treponema Pallidum, Helicobacter Pylori, Malaria, Vibrio Cholerae, Dengue Virus, Rotavirus, Adenovirus, Group A Streptococcus, Chlamydia, Salmonella, Zika, Influenza A, Influenza B, Chagas, Chikungunya,HCG, FSH Menopause, Male Fertility, Human Chronic Gonadotrophin, LH Ovulation, Amphetamine, Barbiturates, Benzodiazepine, Cocaine, MDMA, Morphine (MOR), Opiates(OPI), Methadone (MTD), Tricyclic Antidepressants, Tetrahydrocannabinol (THC), Buprenorphine (BUP), Oxycodone (Oxy), Ketamine(KET), Phencyclidine (PCP), Marijuana (K2), Fentanyl (FYL), Fatty Acid, Troponin, Creatine Kinase Isoenzymnes, Myoglobin, C Reactive Protein, Covid-19, SARS-CoV-2, Coronavirus, Cancer, Staphylococcus,Blood Disorders, Vitamin levels, Respiratory Disease, SARS, Urinary Infections, Fertility, Cardiac Markers, Tumor Markers, Drug Abuse, Digestive and Immune Disorders, Sexually Transmitted Diseases (STD), Herpes, Infectious Diseases, and parvo for point of care, laboratory, and home use; Medical diagnostic testing apparatus for medical oncology use; Rapid medical diagnostic testing apparatus for medical oncology use; Medical diagnostic testing apparatus for medical oncology use for oncology for point of care, laboratory, and home use; Medical diagnostic testing apparatus to test for cardiac markers; Medical diagnostic testing apparatus for conducting antibody tests; Rapid medical diagnostic testing apparatus for conducting antibody tests; Medical diagnostic antibody diagnostic testing apparatus for conducting antibody tests for point of care, laboratory, and home use; Medical diagnostic testing apparatus to check for the presence and amount of vitamin D; Rapid medical diagnostic testing apparatus to check for the presence and amount of Vitamin D; Medical diagnostic testing apparatus to check for the presence and amount of Vitamin D for point of care, laboratory, and home use; Medical diagnostic testing apparatus to check for the presence and amount of opioids; Rapid medical diagnostic testing apparatus to check for the presence and amount of opioids; Medical diagnostic testing apparatus to check for the presence and amount of opioids for point of care, laboratory, and home use; Testing kits comprised of medical devices and diagnostic reagents and assays for testing bodily fluids, blood, DNA, RNA, and skin; Testing kits comprised of medical devices and diagnostic reagents and assays for rapid testing bodily fluids, blood, DNA, RNA, and skin; Testing kits comprised of medical devices and diagnostic reagents and assays for testing bodily fluids, blood, DNA, RNA, and skin for point of care, laboratory, and home use; Medical diagnostic testing apparatus to check for the presence and size of tumors; Rapid medical diagnostic testing apparatus to check for the presence and size of tumors; Medical diagnostic testing apparatus to check for the presence and size of tumors for point of care, laboratory, and home use; Rapid, single-use molecular diagnostic test kit comprised of medical testing apparatus, reagents, assays for the qualitative detection of SARS-CoV-2 RNA from self-collected nasal swab specimens; Rapid, single-use molecular diagnostic test kit comprised of medical testing apparatus, reagents, assays for the qualitative detection of SARS-CoV-2 RNA with isothermal amplification (LAMP) and test results displayed via LED indicators; Rapid, single-use molecular diagnostic test kit comprised of medical testing apparatus, reagents, assays for the qualitative detection of SARS-CoV-2 RNA with Positive Internal Control (PIC) and Lysis Internal Control (LIC) contained within the test unit; Syndromic infectious disease testing devices for medical use; Syndromic Infectious disease testing devices for medical use for testing for severe acute respiratory syndrome; Nucleic acid testing devices for medical use for testing for qualitative detection of respiratory viral and bacterial nucleic acids

Classification Information


International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateWednesday, August 10, 2022
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NamePrecision Therapeutics, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressPark Ridge, NJ 07656

Party NamePrecision Therapeutics, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressPark Ridge, NJ 07656

Trademark Events


Event DateEvent Description
Thursday, July 22, 2021NEW APPLICATION ENTERED
Tuesday, September 21, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, July 28, 2021TEAS VOLUNTARY AMENDMENT RECEIVED
Wednesday, July 28, 2021TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED
Wednesday, February 9, 2022NON-FINAL ACTION E-MAILED
Tuesday, February 8, 2022ASSIGNED TO EXAMINER
Wednesday, February 9, 2022NON-FINAL ACTION WRITTEN
Wednesday, February 9, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, August 10, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, August 9, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, August 9, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, September 14, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, August 26, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, October 4, 2022PUBLISHED FOR OPPOSITION
Tuesday, October 4, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Saturday, May 20, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, November 29, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, May 18, 2023SOU TEAS EXTENSION RECEIVED
Thursday, May 18, 2023SOU EXTENSION 1 FILED
Thursday, May 18, 2023SOU EXTENSION 1 GRANTED
Wednesday, November 22, 2023SOU TEAS EXTENSION RECEIVED
Friday, November 24, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, May 24, 2024SOU TEAS EXTENSION RECEIVED
Friday, May 24, 2024SOU EXTENSION 3 GRANTED
Friday, May 24, 2024SOU EXTENSION 3 FILED
Wednesday, November 22, 2023SOU EXTENSION 2 GRANTED
Wednesday, November 22, 2023SOU EXTENSION 2 FILED